Tumours of the Urinary System 2: Urothelial and Renal Cancers Flashcards

1
Q

what are sites of urothelial tumours?

A

Malignant tumours of the lining transitional cell epithelium (urothelium) can occur at any point
from renal calyces
to the tip of the urethra.

Most common site - bladder - 90%
“Bladder Cancer”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the most common tumour type for bladder cancer?

A

transitional cell carcinoma (i.e. 90% in UK)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the risk factors for bladder cancer?

A

smoking (accounts for 40% of cases)
aromatic amines
non-hereditary genetic abnormalities (e.g. TSG incl. p53 and Rb)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are risk factors for squamous cell carcinoma bladder cancer?

A

Schistosomiasis (S. haematobium only)
chronic cystitis (e.g. recurrent UTI, long term catheter, bladder stone)
cyclophosphamide therapy
pelvic radiotherapy
Adenocarcinoma
-Urachal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the most frequent presenting symptom of bladder cancer?

A

painless visible haematuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are occasional symptoms of bladder cancer?

A

Occasionally
symptoms due to invasive or metastatic disease

recurrent UTI
storage bladder symptoms
dysuria, frequency, nocturia, urgency +/- urge incontinence
bladder pain
if present, suspect CIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how may haematuria present?

A

Frank - reported by patient
Microscopic - detected by doctor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what should be done urgently in investigation of haematuria?

A

Upper tract imaging
CT Urogram (IVU)
ultrasound scan
Urine Cytology
Limited use in Dipstick haematuria

BP and U&E’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what should be done in investigation of haematuria?

A

Urine culture
majority of painful haematuria = UTI

Cystourethroscopy
commonest neoplastic cause is TCC bladder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what investigations should be done for frank haematuria?

A

> 50 yrs - Risk of malignancy - 25-35%
Flexible cystourethroscopy within 2 weeks
IVU & USS
CT Urogram & USS
Urine Cytology may also be useful (but not very sensitive nor specific)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what investigation should be done for microscopic haematuria?

A

> 50 yrs - Risk of malignancy - 5-10%
Flexible cystourethroscopy within 4-6 weeks
USS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how are urothelial tumours diagnosed?

A

IVU alone will miss a proportion of renal cell tumours (especially if <3cm)

USS alone will miss a proportion of urothelial tumours of the upper tracts

cystoscopy and endoscopic resection (TURBT)
EUA to assess bladder mass/thickening before and after TURBT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how are urothelial tumours in the bladder staged?

A

cross-sectional imaging (CT, MRI)
Bone scan if symptomatic
CTU for upper tract TCC (2-7% risk over 10 years; higher risk if high grade, stage or multifocal bladder tumours)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is treatment available for urothellial tumours of the bladder?

A

endoscopic or radical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how are bladder tumours classified?

A

Grade of tumour

Stage of tumour
- TNM classification
- T-stage :
- non-muscle invasive (or ‘superficial’)
- muscle invasive

Combined to describe TCC e.g. G1pTa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what does appropriate treatment of bladder cancer depend?

A

Site
Clinical stage
Histological grade of tumour
Patient age and co-morbidities

17
Q

what is treatment for Low grade non-muscle invasive (i.e. Ta or T1)?

A

endoscopic resection followed by single instillation of intravesical chemotherapy (mitomycin C) within 24 hours
prolonged endoscopic follow up for moderate grade tumours
consider prolonged course of intravesical chemotherapy (6 weeks months) for repeated recurrences

18
Q

what is treatment for High grade non-muscle invasive or CIS?

A

very aggressive – 50-80% risk of progression to muscle invasive stage
endoscopic resection alone not sufficient
CIS consider intravesical BCG therapy (maintenance course, weekly for 3 weeks repeated 6 monthly over 3 years)
patients refractory to BCG – need radical surgery

19
Q

what is treatment for muscle invasive bladder (T2 - T3)?

A

neoadjuvant chemotherapy for local (i.e. downstaging) and systemic control; followed by either :
radical radiotherapy and/or;
radical cystoprostatectomy (men) or anterior pelvic exenteration with urethrectomy (women); with extended lymphadenectomy
radical surgery combined with incontinent urinary diversion (i.e. ileal conduit), continent diversion (e.g. bowel pouch with catheterisable stoma) or orthotopic bladder substitution

20
Q

what is prognosis of bladder cancer dependent on?

A

stage
grade
size
multifocality
presence of concurrent CIS
recurrence at 3 months

21
Q

what is the five year survival of non-invasive, low grade bladder TCC?

A

90% 5-year survival

22
Q

what is the five year survival of invasive, high grade bladder TCC?

23
Q

Upper tract TCC (or upper tract urothelial cancer – UTUC) main symptoms?

A

Frank haematuria
Unilateral ureteric obstruction
Flank or loin pain
Symptoms of nodal or metastatic disease
Bone pain
Hypercalcaemia
Lung
Brain

24
Q

what diagnostic investigations are done for UTUC?

A

CT-IVU or IVU

Urine cytology

Ureteroscopy and biopsy

25
what will IVU/CT-IVU show in UTUC?
shows filling defect in renal pelvis
26
upper tract TCC?
renal pelvis or collecting system commonest ureter less commonly tumours are often high-grade and multifocal on one side high risk of local recurrence if treated endoscopically or by segmental resection low risk of having contralateral disease difficult to follow up if treated endoscopically hence, most upper tract TCCs are treated by nephro-ureterectomy
27
indications for treatment in UTUC?
If unfit for nephro-ureterectomy or has bilateral disease - absolute indication for nephron-sparing endoscopic treatment (i.e. ureteroscopic laser ablation); needs regular surveillance ureteroscopy If unifocal and low-grade disease - relative indication for endoscopic treatment In ALL cases, high risk of synchronous and metachronous bladder TCC (40% over 10 years); hence need surveillance cystoscopy
28
what are examples of benign renal tumours?
oncocytoma, angiomyolipoma
29
what are examples of malignant renal tumours?
renal adenocarcinoma commonest adult renal malignancy synonyms : hypernephroma or Grawitz tumour most arise from proximal tubules histological subtypes : clear cell (85%) papillary (10%) chromophobe (4%) Bellini type ductal carcinoma (1%)
30
what are risk factors for renal adenocarcinoma?
Family history (autosomal dominant e.g. vHL, familial clear cell RCC, hereditary papillary RCC; can be bilateral and/or multifocal) Smoking Anti-hypertensive medication Obesity End-stage renal failure Acquired renal cystic disease
31
what is the presentation of renal adenocarcinoma?
Asymptomatic (i.e. incidentally noted on imaging for unrelated symptoms) : 50% ‘Classic triad’ of flank pain, mass and haematuria : 10% Paraneoplastic syndrome : 30% anorexia, cachexia and pyrexia hypertension, hypercalcaemia and abnormal LFTs anaemia, polycythaemia and raised ESR Metastatic disease : 30% bone, brain, lungs, liver
32
how is renal cancer staged?
T1 - Tumour < 7cm confined within renal capsule T2 - Tumour >7cm & confined within capsule T3 - Local extension outside capsule T3a - Into adrenal or peri-renal fat T3b - Into renal vein or IVC below diaphragm T3c - Tumour thrombus in IVC extends above diaphragm T4 - Tumour invades beyond Gerota’s fascia
33
what are the different mechanisms of spread for renal adenocarcinoma?
Direct spread (invasion) through the renal capsule Venous invasion to renal vein and vena cava Haematogenous spread to lungs and bone Lymphatic spread to paracaval nodes
34
what investigations are done for renal adenocarcinoma?
CT scan (triple phase) of abdomen and chest is mandatory provides radiological diagnosis and complete TNM staging assesses contralateral kidney Bloods : U&E, FBC Optional tests : Ultrasound differentiates tumour from cyst DMSA or MAG-3 renogram to assess split renal function if doubts about contralateral kidney
35
what is the treatment for renal adenocarcinoma?
Treatment is surgical – i.e. radical nephrectomy laparoscopic radical nephrectomy is standard of care for T1 tumours (T2 tumours in laparoscopic centres) worthwhile even with major venous invasion (≥T3b) curative if ≤T2 Even in patients with metastatic disease who have symptoms from primary tumour, palliative cytoreductive nephrectomy is beneficial (prolongs median survival by 6 months)
36
how are metastases of renal adenocarcinoma treated?
Metastases - little effective treatment since RCC is radioresistant and chemoresistant multitargeted receptor tyrosine kinase inhibitors relatively new sunitinib, sorafenib, panzopanib,temsirolimus superior response rates to immunotherapy trials ongoing immunotherapy Interferon alpha Interleukin-1
37
what is the prognosis for different stages of renal carcinoma?
T1 – 95% 5-year survival T2 – 90% 5-year survival T3 – 60% 5-year survival T4 – 20% 5-year survival N1 or N2 – 20% 5-year survival M1 – Median survival 12-18 months